Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #1,271 to #1,320.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Light source → Light sources
  2. LIMB → Limbs International Medical Buflomedil Trial
  3. LIMIT AMI → Limitation Of Myocardial Infarction Following Thrombolysis In Acute
  4. LEADERS → Limus Eluted From A Durable Vs Erodable Stent Coating
  5. Lips → Lip (disambiguation)
  6. L-CAD → Lipid-Coronary Artery Disease (Pravastatin)
  7. SLIP → Lipid Profile During Antihypertensive Treatment
  8. LRC-CPPT → Lipid Research Clinics Coronary Primary Prevention Trial
  9. Ddx:Lipoprotein (a) → Lipoprotein (a)
  10. Hyperlipidemia case study one → Lipoprotein disorders case study one
  11. Hyperlipidemia cost-effectiveness of therapy → Lipoprotein disorders cost-effectiveness of therapy
  12. Hyperlipidemia differential diagnosis → Lipoprotein disorders differential diagnosis
  13. Hyperlipidemia epidemiology and demographics → Lipoprotein disorders epidemiology and demographics
  14. Hyperlipidemia future or investigational therapies → Lipoprotein disorders future or investigational therapies
  15. Hyperlipidemia history and symptoms → Lipoprotein disorders history and symptoms
  16. Hyperlipidemia laboratory findings → Lipoprotein disorders laboratory findings
  17. Hyperlipidemia medical therapy → Lipoprotein disorders medical therapy
  18. Hyperlipidemia natural history, complications and prognosis → Lipoprotein disorders natural history, complications and prognosis
  19. Hyperlipidemia pathophysiology → Lipoprotein disorders pathophysiology
  20. Genetics of lipoprotein disorders → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  21. Genetics of primary lipoprotein disorders → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  22. Lipoprotein disorders genetics → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  23. Dyslipidemia genetics → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  24. Genes in hyperlipidemia → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  25. Hyperlipidemia physical examination → Lipoprotein disorders physical examination
  26. Hyperlipidemia risk factors → Lipoprotein disorders risk factors
  27. Hyperlipidemia screening → Lipoprotein disorders screening
  28. Lippincott Williams and Wilkins → Lippincott Williams & Wilkins
  29. Lisinopril Pregnancy → Lisinopril pregnancy
  30. List of notable people diagnosed with Crohn's disease → List of people diagnosed with Crohn's disease
  31. Chemistry journal → List of scientific journals in chemistry
  32. Statistical package → List of statistical packages
  33. Atrophie Blanche → Livedoid Vasculitis
  34. WikiDoc state of the art review on Lo Ovral → Lo Ovral detailed information
  35. Gamma-One → Localized Intracoronary Gamma-Radiation Therapy To Inhibit The Recurrence Of Restenosis After Stenting
  36. LAMP → Locally Advanced Multimodality Protoco
  37. Lognormal distribution → Log-normal distribution
  38. Lognormal → Log-normal distribution
  39. LADIP → Loire-Ardèche-Drôme-Isère-Puy-De-Dôme
  40. ENCORE II → Long-Term Effect Of Nifedipine On Vasomotion And Vessel Morphology In Patients With Coronary Artery Disease: An Intravascular Ultrasound-Assisted Evaluation
  41. SCAT → Long-Term Effects Of Cholesterol Lowering And Angiotension-Converting Enzyme Inhibition On Coronary Atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (Scat).
  42. LIPID → Long-Term Intervention With Pravastatin In Ischemic Disease Trial
  43. SPIC → Long-Term Survival Effect Of Metoprolol In Dilated Cardiomyopathy
  44. Long haul COVID → Long COVID syndrome
  45. ELITE-II → Losartan Heart Failure Survival Study
  46. LIFE → Losartan Intervention For Endpoint Reduction In Hypertension (Life) Study
  47. Louis J. Ignarro → Louis Ignarro
  48. Pasteur → Louis Pasteur
  49. Love bite → Love-bite
  50. REDUCE → Low Molecular Weight Heparin (Reviparin) In Percutaneous Transluminal Coronary Angioplasty

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"